GlaxoSmithkline Pharmaceuticals (GLAXO.NSE) Q1 2026 Earnings

9FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
12.29
13.82
15.34
16.87

Details

Expected EPS
N/A
Actual EPS
16.865138993749998
Surprise EPS
16.87
Surprise Percent
+∞%

Description

GlaxoSmithkline Pharmaceuticals (GLAXO.NSE) has reported earnings of 16.865138993749998 per share for Q1 2026.

0 Comments

Share your thoughts